LIFE:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund Hedged Units (CAD)

COMMON STOCK | |

Last Closing

CAD 21.02

Change

0.00 (0.00)%

Market Cap

CAD 0.01B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
TD-PFB:CA Toronto Dominion Bank Pref B

-0.11 (-0.46%)

CAD 192.55B
TD-PFD:CA Toronto Dominion Bank Pref D

-0.04 (-0.17%)

CAD 163.57B
TD-PFI:CA Toronto-Dominion Bank Pref Ser..

+0.08 (+0.32%)

CAD 159.30B
TD-PFM:CA Toronto-Dominion Bank Pref Ser..

+0.02 (+0.08%)

CAD 141.54B
TD-PFL:CA Toronto-Dominion Bank Pref Ser..

N/A

CAD 141.31B
ENB-PFV:CA Enbridge Inc Pref 5

+0.10 (+0.45%)

CAD 112.04B
ENB-PFA:CA Enbridge Inc Pref 9

-0.01 (-0.05%)

CAD 111.75B
ENB-PFC:CA Enbridge Inc Pref 11

+0.05 (+0.28%)

CAD 106.53B
ENB-PFG:CA Enbridge Inc Pref 15

+0.08 (+0.47%)

CAD 101.09B
ENB-PFU:CA Enbridge Inc Pref L

+0.11 (+0.53%)

CAD 81.88B

ETFs Containing LIFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.11% N/A N/A 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.11% N/A N/A 33% F
Trailing 12 Months  
Capital Gain -3.71% N/A N/A 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.71% N/A N/A 24% F
Trailing 5 Years  
Capital Gain 10.81% N/A N/A 50% F
Dividend Return 6.19% N/A N/A 28% F
Total Return 17.00% N/A N/A 46% F
Average Annual (5 Year Horizon)  
Capital Gain 1.65% N/A N/A 49% F
Dividend Return 2.81% N/A N/A 49% F
Total Return 1.16% N/A N/A 38% F
Risk Return Profile  
Volatility (Standard Deviation) 7.37% N/A N/A 78% C+
Risk Adjusted Return 38.05% N/A N/A 64% D
Market Capitalization 0.01B N/A N/A 9% A-

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike